|
TSEN34 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.156000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.064800E-01 |
| Normal-vs-Stage2 |
3.599000E-01 |
| Normal-vs-Stage3 |
8.295800E-01 |
| Normal-vs-Stage4 |
1.197790E-01 |
| Stage1-vs-Stage2 |
6.468300E-02 |
| Stage1-vs-Stage3 |
2.041400E-01 |
| Stage1-vs-Stage4 |
3.998000E-01 |
| Stage2-vs-Stage3 |
4.671000E-01 |
| Stage2-vs-Stage4 |
3.004100E-02 |
| Stage3-vs-Stage4 |
9.759700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.240200E-01 |
| Normal-vs-AfricanAmerican |
6.516000E-02 |
| Normal-vs-Asian |
7.163600E-01 |
| Caucasian-vs-AfricanAmerican |
4.650400E-02 |
| Caucasian-vs-Asian |
7.541800E-01 |
| AfricanAmerican-vs-Asian |
9.200600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.751800E-01 |
| Normal-vs-Female |
4.402300E-02 |
| Male-vs-Female |
2.863400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.470000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.206400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.272000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.087000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.349800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.225200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.985400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.028600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.157200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.232000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.807800E-02 |
| Normal-vs-Grade 2 |
3.784600E-01 |
| Normal-vs-Grade 3 |
5.170200E-01 |
| Normal-vs-Grade 4 |
7.859800E-01 |
| Grade 1-vs-Grade 2 |
1.513420E-01 |
| Grade 1-vs-Grade 3 |
1.861980E-01 |
| Grade 1-vs-Grade 4 |
7.398300E-02 |
| Grade 2-vs-Grade 3 |
7.609200E-01 |
| Grade 2-vs-Grade 4 |
2.420800E-01 |
| Grade 3-vs-Grade 4 |
4.148000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.900200E-01 |
| Normal-vs-ccB subtype |
3.407800E-01 |
| ccA subtype-vs-ccB subtype |
8.881600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.351400E-01 |
| Normal-vs-N1 |
3.473200E-01 |
| N0-vs-N1 |
3.559400E-01 |
|
|
